CDW vs DMAC · P/E 22, rev $21.00B vs $157.4M cap
CDW Corp (CDW) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
CDW Corp (CDW) is a information technology services company listed on US.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported CDW revenue for 2024-12-31 was $21.00B. Net income was $1.08B. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CDW currently screens at market cap $23.36B and trailing P/E 22.0.
DMAC does not have a complete income-statement cache yet.
CDW currently screens at market cap $23.36B and trailing P/E 22.0. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the CDW and DMAC stock pages for the full models.
Not investment advice.